Invesco
OPRX icon

Invesco’s OptimizeRx OPRX Stock Holding History

Invesco’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-199,091
Closed -$4.08M – 3827
2025
Q3 		$4.08M Buy
+199,091
New +$3.16M ﹤0.01% 2321
2025
Q2 		– Sell
-293,554
Closed -$2.54M – 3835
2025
Q1 		$2.54M Buy
+293,554
New +$1.79M ﹤0.01% 2446
2024
Q3 		– Sell
-14,045
Closed -$140K – 3843
2024
Q2 		$140K Sell
14,045
-8,070
-36% -$88.6K ﹤0.01% 3706
2024
Q1 		$269K Buy
+22,115
New +$321K ﹤0.01% 3558
2023
Q1 		– Sell
-80,479
Closed -$1.35M – 3967
2022
Q4 		$1.35M Sell
80,479
-29,311
-27% -$507K ﹤0.01% 2802
2022
Q3 		$1.63M Buy
109,790
+4,309
+4% +$85.2K ﹤0.01% 2731
2022
Q2 		$2.89M Sell
105,481
-2,534
-2% -$75.1K ﹤0.01% 2554
2022
Q1 		$4.07M Sell
108,015
-3,418
-3% -$151K ﹤0.01% 2473
2021
Q4 		$6.92M Buy
111,433
+20,631
+23% +$1.56M ﹤0.01% 2225
2021
Q3 		$7.77M Buy
90,802
+81,452
+871% +$5.11M ﹤0.01% 2147
2021
Q2 		$579K Buy
9,350
+1,824
+24% +$92.8K ﹤0.01% 3349
2021
Q1 		$367K Sell
7,526
-46,175
-86% -$2.23M ﹤0.01% 3466
2020
Q4 		$1.67M Buy
53,701
+8,104
+18% +$199K ﹤0.01% 2702
2020
Q3 		$950K Buy
+45,597
New +$783K ﹤0.01% 2844

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco's OPRX Position: Q4 2025 in Review

Invesco sold out of OptimizeRx (OPRX) in Q4 2025, closing a stake of 199,091 shares — an estimated $4.08M sold.

Invesco first reported a position in OPRX in Q3 2020 and held it in 14 quarters. The position peaked at $7.77M in Q3 2021. 129 funds tracked by Wall St. Rank hold OPRX as of Q4 2025.

  • Invesco reported no remaining OptimizeRx position as of Q4 2025 after selling out during the quarter.
  • Invesco sold 199,091 OptimizeRx shares in Q4 2025, an estimated $4.08M.
  • Invesco first reported a position in OptimizeRx in Q3 2020 and held it in 14 quarters.
  • Invesco's OptimizeRx position peaked at $7.77M in Q3 2021.
  • 129 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2025.

Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.